WallStreetZenWallStreetZen

NASDAQ: BBIO
Bridgebio Pharma Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Bridgebio Pharma earnings were -$691.9M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest BBIO earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$152.2M, down 7.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BBIO reported annual earnings of -$724.9M, with 35.3% growth. The next BBIO earnings date is Nov 4, 2026.

BBIO earnings history

Current Revenue
$713.1M
Current Earnings
-$691.9M
Current Profit Margin
-97%

BBIO Return on Equity

Insufficient data to display

BBIO Return on Assets

Current Company
-61.2%
Current Industry
-10.2%
BBIO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BBIO announces earnings.

BBIO Return on Capital Employed

Current Company
-197.13%
Current Industry
-6.7%
BBIO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BBIO vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BBIO-$633.10M-$691.87MN/A-$3.56
SMMT-$855.92M-$856.09MN/A-$0.01
EXEL$1.09B$860.62M+60.39%$3.29
BMRN$385.69M$72.97M-39.24%$0.38
JAZZ$1.62B$940.76M+68.91%$15.26
View Top Biotech Stocks

BBIO earnings dates

Next earnings date
Nov 4, 2026

Bridgebio Pharma Earnings Reports & History FAQ

What were Bridgebio Pharma's earnings last quarter?

On BBIO's earnings call on Aug 10, 2026, Bridgebio Pharma (NASDAQ: BBIO) reported Q2 2026 earnings per share (EPS) of -$0.78, up 17.89% year over year. Total BBIO earnings for the quarter were -$152.22 million. In the same quarter last year, Bridgebio Pharma's earnings per share (EPS) was -$0.95.

If you're new to stock investing, here's how to buy Bridgebio Pharma stock.

When does Bridgebio Pharma report earnings?

The next BBIO earnings date is Nov 4, 2026. Add BBIO to your watchlist to be reminded of Bridgebio Pharma's next earnings date.

Is Bridgebio Pharma profitable or losing money?

As of the last Bridgebio Pharma earnings report, Bridgebio Pharma is currently losing money. Bridgebio Pharma's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$691.87 million, a 10.89% decrease year over year.

What was BBIO's earnings growth in the past year?

As of Bridgebio Pharma's earnings date in Aug 10, 2026, Bridgebio Pharma's earnings has grown year over year. BBIO earnings in the past year totalled -$691.87 million.

What are Bridgebio Pharma's earnings expectations?

The current EPS estimate for Bridgebio Pharma's earnings report in Nov 4, 2026 is -$0.67.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.